Partnership for Part D Access
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us

Newsroom​ 

Patient Advocates Applaud Biden Administration for Maintaining Medicare's Six Protected Classes Policy

3/16/2021

1 Comment

 
Contact: Shea McCarthy 
smccarthy@thornrun.com
(202) 285-3866
FOR IMMEDIATE RELEASE
March 16, 2021
Picture
​Washington D.C. — The Partnership for Part D Access, a broad-based coalition of health care stakeholders including diverse patient advocacy organizations that represent patients who benefit from treatments covered under each of Medicare’s “six protected classes,” commended the Centers for Medicare and Medicaid Services (CMS) for rejecting a proposal that would have substantially weakened Medicare’s six protected classes policy.

Medicines in the six protected classes treat serious health conditions that impact the most vulnerable beneficiaries — the frail, disabled or those with multiple chronic conditions. For these individuals, many medicines are not interchangeable. Seemingly similar patients often respond differently to the same drug: while one patient may respond well, a similar patient will have a suboptimal response, or worse. Further, drugs in the same class often have different side effects, and patients are sometimes better suited to one particular drug over another. The six protected classes policy gives doctors the ability to prescribe the right drug for the patients in their care.
 
“Medicare beneficiaries with the most complex, chronic conditions are breathing a sigh of relief,” said Chuck Ingoglia, President and CEO of the National Council for Behavioral Health, who serves as Executive Director of the Partnership for Part D Access. “The Biden administration’s decision demonstrates the need to maintain the six protected classes policy as an essential patient safeguard in Medicare Part D.”
 
As detailed in a CMS’ announcement, this decision was “based on stakeholder feedback and other considerations.” Notably, stakeholder feedback on the proposal included the following outreach from bipartisan Members of Congress, diverse patient advocacy groups, and others:
 
  • 67 bipartisan Members of Congress signed a letter to HHS and CMS urging them to withdraw the proposal;
  • several thousand patients from across the country wrote letters to the CMS comment portal;
  • over 130 individual patient groups joined a letter to HHS Secretary-designate Xavier Becerra;
  • nine leading pharmacy stakeholder groups penned a letter to the Acting CMMI Director Amy Bassano;
  • the Center for Medicare Advocacy and Medicare Rights Center sent a letter to Acting HHS Secretary Norris Cochrane; and
  • a group of 30 leading HIV groups sent a letter to HHS Secretary-designate Becerra.
1 Comment
Jred Hatty
7/24/2022 07:13:15 pm

I TESTED POSITIVE FOR HSV-2 A FEW MONTHS AGO.
At first, Yes, I was devastated thinking I have an incurable STD for life. After doing hours of research I quickly realized genital herpes is a filthy parasite that just likes to hide in your body. Yes, There’s no “medical cure” but that doesn’t mean your body can’t get rid of it. I literally flush it out of my system with the help of Doctor Azuka, A natural herbal medicine which I ordered after doing some research. And now I’m HSV-2 negative, I never believed it until my doctor finally gave me the test results and behold I was HSV-2 free. I’m so glad that I found you, Doctor Azuka. Thanks so much for your goodness I’m grateful. You can also get your help from him through his
Email } dr.azukasolutionhome@gmail.com
WhatsApp } +2349166175418

Reply



Leave a Reply.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    September 2022
    November 2021
    March 2021
    February 2021
    January 2021
    November 2020
    January 2020
    July 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    April 2018
    March 2018
    September 2017
    May 2017
    April 2017
    November 2016
    July 2016

    Categories

    All

    RSS Feed

Learn more

About Us
Patient Communities
​Issues
​Background

What's New?

​Newsroom
Resources
​

Contact

Contact Us
© COPYRIGHT 2018. ALL RIGHTS RESERVED.